(Q51712832)

English

A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.

scientific article published on 3 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

Helicobacter pylori

0 references

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

2

object named as

Nayoung Kim

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

8

object named as

Hyun Chae Jung

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

3

object named as

Jung Mogg Kim

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

4

object named as

Ryoung Hee Nam

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

author name string

Jung Won Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

Jae Yeon Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

Ju Yup Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

Dong Ho Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

publication date

3 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

49

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

8

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

917-924

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Helicobacter pylori treatment in the era of increasing antibiotic resistance

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

H. pylori treatment: new wine in old bottles?

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Empiric therapies for Helicobacter pylori infections

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

[Comparison of rifabutin- and levofloxacin-based third-line rescue therapies for Helicobacter pylori].

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Understanding and appreciating sequential therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Optimal therapy for Helicobacter pylori infections

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Modified sequential therapy regimens for Helicobacter pylori eradication: a systematic review

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Regional difference of antibiotic resistance of helicobacter pylori strains in Korea

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2014.896409

21 January 2018

Identifiers

10.3109/00365521.2014.896409

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/24988873

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51712832&oldid=1856443440"